Evidence map›Paper›PMID 32511278›Full record

ArticlePloS one2020

Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B.

Hideki Hayashi, Ting Wang, Masayuki Tanaka, Sanae Ogiwara, Chisa Okada, Masatoshi Ito, Nahoko Fukunishi, Yumi Iida, Ayaka Nakamura, Ayumi Sasaki and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. HaloTag as a substrate-based macroautophagy reporter.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. When autophagy meets placenta development and pregnancy complications.Frontiers in cell and developmental biology · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Hideki HayashiSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Ting WangSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Masayuki TanakaSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Sanae OgiwaraSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Chisa OkadaSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.ORCID 0000-0002-5910-4045
Masatoshi ItoSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Nahoko FukunishiSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Yumi IidaSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Ayaka NakamuraSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Ayumi SasakiSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Shunji AmanoSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Kazuhiro YoshidaSupport Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan.
Asako OtomoMolecular Neuropathobiology Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Masato OhtsukaGenetic Engineering and Genome Editing Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Shinji HadanoMolecular Neuropathobiology Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan.ORCID 0000-0002-4997-3968
Tokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autophagy-endolysosomal pathway is an evolutionally conserved degradation system that is tightly linked to a wide variety of physiological processes. Dysfunction of this system is associated with many pathological conditions such as cancer, inflammation and neurodegenerative diseases. Therefore, monitoring the cellular autophagy-endolysosomal activity is crucial for studies on the pathogenesis as well as therapeutics of such disorders. To this end, we here sought to create a novel means exploiting Keima, an acid-stable fluorescent protein possessing pH-dependent fluorescence excitation spectra, for precisely monitoring the autophagy-endolysosomal system. First, we generated three lines of transgenic (tg) mouse expressing monomeric Keima-fused MAP1LC3B (mKeima-LC3B). Then, these tg mice were subjected to starvation by food-restriction, and also challenged to neurodegeneration by genetically crossing with a mouse model of amyotrophic lateral sclerosis; i.e., SOD1H46R transgenic mouse. Unexpectedly, despite that a lipidated-form of endogenous LC3 (LC3-II) was significantly increased, those of mKeima-LC3B (mKeima-LC3B-II) were not changed under both stressed conditions. It was also noted that mKeima-LC3B-positive aggregates were progressively accumulated in the spinal cord of SOD1H46R;mKeima-LC3B double-tg mice, suggestive of acid-resistance and aggregate-prone natures of long-term overexpressed mKeima-LC3B in vivo. Next, we characterized mouse embryonic fibroblasts (MEFs) derived from mKeima-LC3B-tg mice. In contrast with in vivo, levels of mKeima-LC3B-I were decreased under starved conditions. Furthermore, when starved MEFs were treated with chloroquine (CQ), the abundance of mKeima-LC3B-II was significantly increased. Remarkably, when cultured medium was repeatedly changed between DMEM (nutrient-rich) and EBSS (starvation), acidic/neutral signal ratios of mKeima-LC3B-positive compartments were rapidly and reversibly shifted, which were suppressed by the CQ treatment, indicating that intraluminal pH of mKeima-LC3B-positive vesicles was changeable upon nutritional conditions of culture media. Taken together, although mKeima-LC3B-tg mice may not be an appropriate tool to monitor the autophagy-endolysosomal system in vivo, mKeima-LC3B must be one of the most sensitive reporter molecules for monitoring this system under in vitro cultured conditions.

Indexed as

AnimalsAutophagyCells, CulturedCulture MediaEndosomesFemaleFibroblastsHumansHydrogen-Ion ConcentrationLuminescent ProteinsLysosomesMaleMice, Inbred C57BLMice, TransgenicMicrotubule-Associated ProteinsMutationCulture MediaLuminescent ProteinsMAP1LC3B protein, humanMicrotubule-Associated ProteinsRecombinant Fusion ProteinsSod1 protein, mouseSuperoxide Dismutase-1

Identifiers

PMID32511278
PMCPMC7279612
OpenAlexW3033236526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.